Navigation Links
Gene-engineered flies are pest solution
Date:1/26/2009

For the first time, male flies of a serious agricultural pest, the medfly, have been bred to generate offspring that die whilst they are still embryos. Researchers writing in the open access journal BMC Biology describe the creation of the flies that, when released into a wild population, could out-compete the normal male flies and cause a generation of pests to be stillborn protecting important crops.

Ernst A. Wimmer from the Georg-August-University in Gttingen, Germany, led an international team of researchers who developed the lethal Mediterranean fruit flies (Ceratitis capitata), also known as medfly. He said, "Here, we present the first alternative, radiation-free, reproductive sterility system for medfly based on transgenic embryonic lethality".

The medfly is a devastating and economically important pest. The currently used method of controlling it is the sterile insect technique (SIT), whereby male flies are irradiated to induce reproductive sterility and then released into the wild, where competition with fertile males reduces the overall insect population. This radioactive version of the SIT has the drawback that the irradiated males are often less competitive than their wild brethren and so an awkward balance must be stuck between competitiveness and degree of sterility. According to Wimmer, "When transgenic males carrying our transgenic system mate with wild females, all progeny die during embryogenesis without the need for radiation. Due to the complete lethality, no fruit damage from developing larvae will occur and no transgenes can pass into the wild population. Moreover, males carrying this system are highly competitive".

In order to suppress the lethality system during rearing of the flies, supplements are added to their food that switch off the genetic self-destruct. The authors write that, "Use of our embryonic lethality system, without the need for radiation, can increase the safety of SIT programs, since accidental releases would not lead to infestations of the environment and possible risks coming from isotopic sources can be eliminated for workers and the environment".


'/>"/>

Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-020-707-94804
BioMed Central
Source:Eurekalert

Related biology technology :

1. It takes nerves for flies to keep a level head
2. BioLife Solutions Launches BioPreservation Today(R) Industry Newsletter
3. London-Based Double Helix Consulting Launches US Division for Strategic Pricing, Reimbursement and Market Access Solutions
4. ICON Delivers New Electronic Solution to Expedite Clinical Trial Adjudication
5. HiveMind Marketing to Enhance Search Results for Chemistry Solutions Leader ChemBridge
6. Elsevier Introduces Breakthrough Technology Intelligence Solution for Accelerating R&D and Innovation in Europe
7. onTargetjobs Offers Employers New Recruitment Solutions to Reach Local Career Candidates
8. Jubilant Biosys Launches Legend NGSS(TM) Advanced Software Solution for High-Throughput Drug Molecule Screening
9. Perceptive Informatics Enters License Agreement With EuroQoL Group to Provide Enhanced Standardization for ePRO Solution
10. BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
11. DuPont Acquires Ag Data Management Business to Enhance Information Solutions for Growers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 , ... This CAST literature ... for biotech crops. The authors focus on the economic effects in countries that are ... of new biotech crops and the resultant risk of low level presence (LLP) puts ...
(Date:12/8/2016)... HOWELL, N.J. , Dec. 8, 2016 /PRNewswire/ ... aquatic augmentation remediation technologies and selected NewTechBio,s NT-MAX ... , a microbial based beneficial bacteria, in conjunction ... Inc., to correct deficiencies with National Pollutant Discharge ... basin 281-8H has experienced a steady history of ...
(Date:12/7/2016)... Diego (PRWEB) , ... December 07, 2016 , ... ... data from its phase I/II dose escalation and expansion clinical trial for its ... in Vienna, Austria. The purpose of the trial was to determine the safety, ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - OncoQuest ... development and commercialization of immunotherapeutic products for the ... entered into an Antibody Manufacturing Development Program with ... , USA) for its oregovomab antibody product. Supported ... Phase IIb clinical study in ovarian cancer patients, ...
Breaking Biology Technology:
(Date:12/5/2016)...  The Office of Justice Programs, National Institute ... Enhance or Replace Medico Legal Autopsies?" on NIJ.gov.  ... replacing forensic autopsies with postmortem X-ray computed tomography, ... response to recommendations made by The National Academy ... as a potential component of medicolegal death investigations. ...
(Date:11/30/2016)... 30, 2016 Not many of us realize that we spend ? of ... we need to do it well. Inadequate sleep levels have been found to lead ... diabetes, and even cancer. Maybe now is the best time to rethink ... them to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... 29, 2016   Neurotechnology , a ... recognition technologies, today released FingerCell 3.0, a ... solutions that run on low-power, low-memory microcontrollers. ... less than 128KB of memory, enabling it ... have limited on-board resources, such as: mobile ...
Breaking Biology News(10 mins):